inks pact with 3 SPVs to acquire a minimum of 26% stake in each entity.
Dr Reddy’s Laboratories
receives form 483 with 4 observations for Andhra Pradesh plant.
clarifies on the cyber-attack news.
board to consider final terms and conditions of buy-back on April 26.
’s rights issue up to Rs25,000cr to open on May 3 till May 17. Board also approved the Letter of Offer to be filed with exchanges. Record date for the issue is set April 24.
to examine status on long-term fund-raising plan up to $2.5bn for FY20 on April 24.
buyout race picks up with Adani, NBCC bids.
Crisil downgrades DHFL’s
commercial paper worth Rs850cr to A3+ from A2+
Srei Equipment Finance and Bank of Baroda to offer joint loans for infrastructure equipment under a new agreement.
Sources say Tata may be waiting in the wings to buy Jet Airways
Brickwork Ratings and CARE Ratings downgrade its rating to A+ and A for Reliance Capital
’s long-term debt programme, market linked debentures and subordinated debt.
GlaxoSmithKline Consumer Healthcare
board to consider the scheme of amalgamation with Hindustan Unilever and self on June 1.
clarified that the company is undergoing a DGCA audit along with the annual main base audit.
GVK Power & Infra
arm signed an agreement with Abu Dhabi Investment Authority and National Investment & Infrastructure Fund for investment in new shares in the Group’s airports holding company equating to a 49% stake.